Annual Total Long Term Liabilities
$59.35 M
+$59.34 M+957091.94%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual total long term liabilities is $59.35 million, with the most recent change of +$59.34 million (+957091.94%) on September 30, 2024.
- During the last 3 years, OTLK annual total long term liabilities has risen by +$47.89 million (+418.22%).
- OTLK annual total long term liabilities is now at all-time high.
Performance
OTLK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$59.35 M
-$28.87 M-32.72%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly total long term liabilities is $59.35 million, with the most recent change of -$28.87 million (-32.72%) on September 1, 2024.
- Over the past year, OTLK quarterly long term liabilities has increased by +$59.29 million (+99473.66%).
- OTLK quarterly long term liabilities is now -57.36% below its all-time high of $139.18 million, reached on March 31, 2024.
Performance
OTLK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
OTLK Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +10000.0% |
| 3 y3 years | +418.2% | +418.2% |
| 5 y5 years | +679.4% | +494.1% |
OTLK Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -57.4% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -57.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -57.4% | >+9999.0% |
Outlook Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $59.35 M(>+9900.0%) | - |
| Sep 2024 | - | $59.35 M(-32.7%) |
| Jun 2024 | - | $88.21 M(-36.6%) |
| Mar 2024 | - | $139.18 M(>+9900.0%) |
| Dec 2023 | - | $59.60 K(+861.3%) |
| Sep 2023 | $6200.00(-89.9%) | $6200.00(-69.0%) |
| Jun 2023 | - | $20.00 K(+141.0%) |
| Mar 2023 | - | $8300.00(-100.0%) |
| Dec 2022 | - | $31.85 M(>+9900.0%) |
| Sep 2022 | $61.40 K(-99.5%) | $61.40 K(-18.9%) |
| Jun 2022 | - | $75.70 K(-75.8%) |
| Mar 2022 | - | $312.30 K(-96.8%) |
| Dec 2021 | - | $9.91 M(-13.5%) |
| Sep 2021 | $11.45 M(+1025.5%) | $11.45 M(+2217.2%) |
| Jun 2021 | - | $494.20 K(-12.2%) |
| Mar 2021 | - | $562.80 K(-94.8%) |
| Dec 2020 | - | $10.87 M(+968.3%) |
| Sep 2020 | $1.02 M | $1.02 M(+23.5%) |
| Jun 2020 | - | $823.60 K(-91.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $9.99 M(-36.5%) |
| Dec 2019 | - | $15.73 M(+106.6%) |
| Sep 2019 | $7.61 M(-31.1%) | $7.61 M(-32.9%) |
| Jun 2019 | - | $11.35 M(-14.2%) |
| Mar 2019 | - | $13.23 M(+4.6%) |
| Dec 2018 | - | $12.64 M(+14.4%) |
| Sep 2018 | $11.05 M(-51.4%) | $11.05 M(-0.3%) |
| Jun 2018 | - | $11.09 M(-1.9%) |
| Mar 2018 | - | $11.30 M(+26.0%) |
| Dec 2017 | - | $8.97 M(-60.5%) |
| Sep 2017 | $22.72 M(+124.0%) | $22.72 M(+234.1%) |
| Jun 2017 | - | $6.80 M(-28.7%) |
| Mar 2017 | - | $9.54 M(-6.0%) |
| Dec 2016 | - | $10.15 M(+0.1%) |
| Sep 2016 | $10.14 M(-62.7%) | $10.14 M(+19.4%) |
| Jun 2016 | - | $8.49 M(-8.9%) |
| Mar 2016 | - | $9.32 M(-7.3%) |
| Dec 2015 | - | $10.06 M(-63.1%) |
| Sep 2015 | $27.22 M(0.0%) | $27.22 M |
| Sep 2014 | $27.22 M | - |
FAQ
- What is Outlook Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Outlook Therapeutics?
- What is Outlook Therapeutics annual total long term liabilities year-on-year change?
- What is Outlook Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly long term liabilities year-on-year change?
What is Outlook Therapeutics annual total long term liabilities?
The current annual total long term liabilities of OTLK is $59.35 M
What is the all time high annual total long term liabilities for Outlook Therapeutics?
Outlook Therapeutics all-time high annual total long term liabilities is $59.35 M
What is Outlook Therapeutics annual total long term liabilities year-on-year change?
Over the past year, OTLK annual total long term liabilities has changed by +$59.34 M (+957091.94%)
What is Outlook Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of OTLK is $59.35 M
What is the all time high quarterly long term liabilities for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly total long term liabilities is $139.18 M
What is Outlook Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, OTLK quarterly total long term liabilities has changed by +$59.29 M (+99473.66%)